CN Patent

CN102076344A — 用于治疗疾病的NF-κB的非激素甾体调节剂

Assigned to Lei Wogen Biological Medicine Co Ltd · Expires 2011-05-25 · 15y expired

What this patent protects

本发明涉及可用于治疗诸如肌营养不良症的神经肌肉疾病的化合物和方法，所述化合物可作为NF-κB抑制剂以治疗或预防包括肌营养不良症在内的肌萎缩疾病。

USPTO Abstract

本发明涉及可用于治疗诸如肌营养不良症的神经肌肉疾病的化合物和方法，所述化合物可作为NF-κB抑制剂以治疗或预防包括肌营养不良症在内的肌萎缩疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN102076344A
Jurisdiction
CN
Classification
—
Expires
2011-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Lei Wogen Biological Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.